G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms

PJ Bates, EM Reyes-Reyes, MT Malik… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Background AS1411 is a 26-mer G-rich DNA oligonucleotide that forms a variety of G-
quadruplex structures. It was identified based on its cancer-selective antiproliferative activity …

New perspectives of physiological and pathological functions of nucleolin (NCL)

W Jia, Z Yao, J Zhao, Q Guan, L Gao - Life sciences, 2017 - Elsevier
Nucleolin (NCL) is a multifunctional protein that mainly localized in the nucleolus, it is also
found in the nucleoplasm, cytoplasm and cell membrane. The three main structural domains …

Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma

MA Taylor, BC Das, SK Ray - Apoptosis, 2018 - Springer
Autophagy is an evolutionarily conserved catabolic process that plays an essential role in
maintaining cellular homeostasis by degrading unneeded cell components. When exposed …

Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands

S Romano, N Fonseca, S Simoes, J Goncalves… - Drug Discovery …, 2019 - Elsevier
Highlights•Nucleolin is overexpressed at the surface cancer cells and tumor
vasculature.•Nucleolin enables dual cellular targeting strategies.•Surface nucleolin as a …

[HTML][HTML] Roles of nucleolin: Focus on cancer and anti-cancer therapy

Z Chen, XH Xu - Saudi medical journal, 2016 - ncbi.nlm.nih.gov
Nucleolin, a multifunctional protein distributed in the nucleolus, participates in many
modulations including rDNA transcription, RNA metabolism, and ribosome assembly …

Iron oxide nanoparticles as carriers for DOX and magnetic hyperthermia after intratumoral application into breast cancer in mice: impact and future perspectives

S Piehler, H Dähring, J Grandke, J Göring, P Couleaud… - Nanomaterials, 2020 - mdpi.com
There is still a need for improving the treatment of breast cancer with doxorubicin (DOX). In
this paper, we functionalized magnetic nanoparticles (MNPs) with DOX and studied the DOX …

Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line

L Gharaibeh, W Alshaer, S Wehaibi, R Al Buqain… - Journal of Drug Delivery …, 2021 - Elsevier
Triple negative breast cancer is an aggressive type of cancer with limited therapeutic
options. Aptamer-functionalized liposomes to deliver short interference RNAs (siRNAs) offer …

AS1411-induced growth inhibition of glioma cells by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 via nucleolin

Y Cheng, G Zhao, S Zhang, F Nigim, G Zhou, Z Yu… - PLoS …, 2016 - journals.plos.org
AS1411 binds nucleolin (NCL) and is the first oligodeoxynucleotide aptamer to reach phase
I and II clinical trials for the treatment of several cancers. However, the mechanisms by which …

Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation

C Xu, Y Wang, Q Tu, Z Zhang, M Chen, J Mwangi, Y Li… - Oncogene, 2019 - nature.com
Pancreatic cancer remains one of the deadliest human cancers despite current advances in
conventional therapeutics including surgery and adjuvant therapies. Here, we showed that …

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy

S Thongchot, K Aksonnam… - International …, 2023 - spandidos-publications.com
The benefits of treating several types of cancers using immunotherapy have recently been
established. The overexpression of nucleolin (NCL) in a number of types of cancer provides …